Millipore Sigma Vibrant Logo

584223 InSolution™ Tetrahydrouridine - CAS 18771-50-1 - Calbiochem

Tetrahydrouridine is a potent competitive inhibitor of cytidine deaminase.

Ficha de datos de seguridad (MSDS o SDS), certificado de análisis y de calidad (CoA y CoQ), expedientes, folletos y otros documentos disponibles.

Sinónimos: 1-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-4-hydroxytetrahydropyrimidin-2(1H)-one, dihydrate, THU, H4U

Primary Target: cytidine deaminase
View Products on Sigmaaldrich.com
584223
Ver precios y disponibilidad

Descripción

Replacement Information

Tabla espec. clave

CAS #Empirical Formula
18771-50-1C₉H₁₆N₂O₆ • 2H₂O

Precios y disponibilidad

Número de referencia DisponiblidadEmbalaje Cant./Env. Precio Cantidad
584223-25MG
Comprobando disponibilidad...
—
Disponibilidad a confirmar Disponibilidad a confirmar
Ingrese cantidad 
Suspendido
Cantidades limitadas disponibles
Debe confirmarse disponibilidad
    El resto: se avisará
      El resto: se avisará
      Se avisará
      Póngase en contacto con el Servicio de Atención al Cliente
      Contact Customer Service

      		 Frasco de vidrio 25 mg
      Recuperando precio...
      No pudo obtenerse el precio
      La cantidad mínima tiene que ser múltiplo de
      Maximum Quantity is
      Al finalizar el pedido Más información
      Ahorró ()
       
      —
      Solicitar precio
      		 —
      Description
      OverviewA potent competitive inhibitor of cytidine deaminase. Used in combination with cytosine arabinoside (Ara-C) to assess the anti-leukemic activity and anti-tumor activity of Ara-C in in vitro studies. The solid form of this compound (Cat. No. 584222) is also available.
      Catalogue Number584223
      Brand Family Calbiochem®
      Synonyms1-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-4-hydroxytetrahydropyrimidin-2(1H)-one, dihydrate, THU, H4U
      References
      ReferencesYusa, K., et al. 1995. Biochem. Biophys. Res. Commun. 206, 486.
      Bouffard, D.Y., et al. 1993. Biochem Pharmacol. 45, 1857.
      Laliberte, J., et al. 1992. Cancer Chemotherap. Pharmacol. 30, 7.
      Riva, C., et al. 1992. Chemotherapy 38, 358.
      Yusa, K., et al. 1992. J. Biol. Chem. 267, 16848.
      Hanze, A.R. 1967. J. Am. Chem. Soc. 89, 6720.
      Product Information
      CAS number18771-50-1
      FormLiquid
      FormulationA 100 mM (25 mg/879 µL) solution of Tetrahydrouridine (Cat. No. 584222) in H₂O.
      Hill FormulaC₉H₁₆N₂O₆ • 2H₂O
      ReversibleY
      Structure formula ImageStructure formula Image
      Quality LevelMQ100
      Applications
      Biological Information
      Primary Targetcytidine deaminase
      Purity≥90% by TLC
      Physicochemical Information
      Cell permeableY
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Dry Ice Only
      Toxicity Standard Handling
      Storage ≤ -70°C
      Protect from Light Protect from light
      Avoid freeze/thaw Avoid freeze/thaw
      Do not freeze Ok to freeze
      Special InstructionsFollowing initial thaw, aliquot and freeze (-70°C). Aliquots are stable for up to 6 months at -70°C.
      Packaging Information
      Packaged under inert gas Packaged under inert gas
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      Número de referencia GTIN
      584223-25MG 04055977264999

      Documentation

      InSolution™ Tetrahydrouridine - CAS 18771-50-1 - Calbiochem Ficha datos de seguridad (MSDS)

      Título

      Ficha técnica de seguridad del material (MSDS) 

      InSolution™ Tetrahydrouridine - CAS 18771-50-1 - Calbiochem Certificados de análisis

      CargoNúmero de lote
      584223

      Referencias bibliográficas

      Visión general referencias
      Yusa, K., et al. 1995. Biochem. Biophys. Res. Commun. 206, 486.
      Bouffard, D.Y., et al. 1993. Biochem Pharmacol. 45, 1857.
      Laliberte, J., et al. 1992. Cancer Chemotherap. Pharmacol. 30, 7.
      Riva, C., et al. 1992. Chemotherapy 38, 358.
      Yusa, K., et al. 1992. J. Biol. Chem. 267, 16848.
      Hanze, A.R. 1967. J. Am. Chem. Soc. 89, 6720.
      Ficha técnica

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision03-January-2019 JSW
      Synonyms1-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-4-hydroxytetrahydropyrimidin-2(1H)-one, dihydrate, THU, H4U
      DescriptionA potent competitive inhibitor of cytidine deaminase. Used in combination with cytosine arabinoside (Ara-C) to assess the anti-leukemic activity and anti-tumor activity of Ara-C in in vitro studies. The solid form of this compound (Cat. No. 584222) is also available.
      FormLiquid
      FormulationA 100 mM (25 mg/879 µL) solution of Tetrahydrouridine (Cat. No. 584222) in H₂O.
      Intert gas (Yes/No) Packaged under inert gas
      CAS number18771-50-1
      Structure formulaStructure formula
      Purity≥90% by TLC
      Storage Protect from light
      Avoid freeze/thaw
      ≤ -70°C
      Do Not Freeze Ok to freeze
      Special InstructionsFollowing initial thaw, aliquot and freeze (-70°C). Aliquots are stable for up to 6 months at -70°C.
      Toxicity Standard Handling
      ReferencesYusa, K., et al. 1995. Biochem. Biophys. Res. Commun. 206, 486.
      Bouffard, D.Y., et al. 1993. Biochem Pharmacol. 45, 1857.
      Laliberte, J., et al. 1992. Cancer Chemotherap. Pharmacol. 30, 7.
      Riva, C., et al. 1992. Chemotherapy 38, 358.
      Yusa, K., et al. 1992. J. Biol. Chem. 267, 16848.
      Hanze, A.R. 1967. J. Am. Chem. Soc. 89, 6720.